InMode (INMD) Cash from Operations Growth (3y) (2021 - 2026)
InMode (INMD) Cash from Operations Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn | -48.14% |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn | 50.11% |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn | -14.75% |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 0.50% |
| 10 | InMode | 978,911.41 | -479.15 Mn | 61.55 Mn | -10.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.01% |
| Dec 31, 2025 | -26.52% |
| Sep 30, 2025 | -18.74% |
| Jun 30, 2025 | -19.98% |
| Mar 31, 2025 | -23.89% |
| Dec 31, 2024 | -15.04% |
| Sep 30, 2024 | -12.30% |
| Jun 30, 2024 | -3.47% |
| Mar 31, 2024 | -0.89% |
| Dec 31, 2023 | 13.72% |
| Sep 30, 2023 | 11.13% |
| Jun 30, 2023 | 242.08% |
| Mar 31, 2023 | 51.10% |
| Dec 31, 2022 | 27.74% |
| Sep 30, 2022 | 49.98% |
| Jun 30, 2022 | 36.43% |
| Mar 31, 2022 | 125.69% |
| Dec 31, 2021 | 77.48% |
| Sep 30, 2021 | 91.16% |
| Jun 30, 2021 | 54.00% |